Factors early in life associated with hepatic steatosis
- PMID: 35978672
- PMCID: PMC9258263
- DOI: 10.4254/wjh.v14.i6.1235
Factors early in life associated with hepatic steatosis
Abstract
Background: The rise in prevalence of non-alcoholic fatty liver disease (NAFLD) mirrors the obesity epidemic. NAFLD is insidious but may gradually progress from simple steatosis to steatohepatitis, fibrosis and cirrhosis and/or hepatocellular carcinoma. Intervention strategies to ameliorate developmental programming of NAFLD may be more efficacious during critical windows of developmental plasticity.
Aim: To review the early developmental factors associated with NAFLD.
Methods: Databases MEDLINE via PubMed, and EMBASE and Reference Citation Analysis were searched and relevant publications up to April 30, 2021 were assessed. Original research studies that included risk factors associated with early development of NAFLD in human subjects were included. These factors include: Maternal factors, intrauterine and prenatal factors, post-natal factors, genetic and ethnic predisposition, childhood and adolescence environmental factors. Studies were excluded if they were review articles or animal studies, case reports or conference abstracts, or if NAFLD was not clearly defined and assessed radiologically.
Results: Of 1530 citations identified by electronic search, 420 duplicates were removed. Of the 1110 citations screened from title and abstract, 80 articles were included in the final analysis. Genetic polymorphisms such as patatin-like phospholipase domain-containing protein 3 (PNPLA3) and membrane-bound O-acyltransferase domain-containing protein 7 (MBOAT7) were associated with increased risk of NAFLD. Familial factors such as maternal obesogenic environment and parental history of hepatic steatosis was associated with offspring NAFLD. Longer duration of exclusive breastfeeding in infancy was associated with a lower risk of developing NAFLD later in life while metabolic dysfunction and/or obesity in adolescence was associated with increased risk of NAFLD. Studies relating to socioeconomic factors and its association with NAFLD reported confounding results.
Conclusion: Maternal metabolic dysfunction during pregnancy, being exclusively breastfed for a longer time postnatally, diet and physical activity in childhood and adolescence are potential areas of intervention to decrease risk of NAFLD.
Keywords: Developmental; Epidemiology; Fatty liver; Natural history; Obesity.
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: All the authors declare that they have no conflict of interest.
Similar articles
-
Genetics Is of the Essence to Face NAFLD.Biomedicines. 2021 Sep 30;9(10):1359. doi: 10.3390/biomedicines9101359. Biomedicines. 2021. PMID: 34680476 Free PMC article. Review.
-
The PNPLA3 rs738409 Variant but not MBOAT7 rs641738 is a Risk Factor for Nonalcoholic Fatty Liver Disease in Obese U.S. Children of Hispanic Ethnicity.Pediatr Gastroenterol Hepatol Nutr. 2021 Sep;24(5):455-469. doi: 10.5223/pghn.2021.24.5.455. Epub 2021 Sep 8. Pediatr Gastroenterol Hepatol Nutr. 2021. PMID: 34557398 Free PMC article.
-
The Membrane-bound O-Acyltransferase7 rs641738 Variant in Pediatric Nonalcoholic Fatty Liver Disease.J Pediatr Gastroenterol Nutr. 2018 Jul;67(1):69-74. doi: 10.1097/MPG.0000000000001979. J Pediatr Gastroenterol Nutr. 2018. PMID: 29601441
-
PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery.Surg Obes Relat Dis. 2016 Dec;12(10):1838-1846. doi: 10.1016/j.soard.2016.06.004. Epub 2016 Jul 1. Surg Obes Relat Dis. 2016. PMID: 27576208
-
Gene Variants Implicated in Steatotic Liver Disease: Opportunities for Diagnostics and Therapeutics.Biomedicines. 2023 Oct 17;11(10):2809. doi: 10.3390/biomedicines11102809. Biomedicines. 2023. PMID: 37893185 Free PMC article. Review.
Cited by
-
Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases.Front Med (Lausanne). 2023 Feb 2;10:1102469. doi: 10.3389/fmed.2023.1102469. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36817797 Free PMC article. Review.
-
Postnatal Consumption of Black Bean Powder Protects against Obesity and Dyslipidemia in Male Adult Rat Offspring from Obese Pregnancies.Nutrients. 2024 Apr 1;16(7):1029. doi: 10.3390/nu16071029. Nutrients. 2024. PMID: 38613062 Free PMC article.
-
Impact of Transgenerational Nutrition on Nonalcoholic Fatty Liver Disease Development: Interplay between Gut Microbiota, Epigenetics and Immunity.Nutrients. 2024 May 3;16(9):1388. doi: 10.3390/nu16091388. Nutrients. 2024. PMID: 38732634 Free PMC article. Review.
-
Single-cell RNA transcriptomics in mice reveals embryonic origin of fibrosis due to maternal obesity.EBioMedicine. 2024 Nov;109:105421. doi: 10.1016/j.ebiom.2024.105421. Epub 2024 Oct 30. EBioMedicine. 2024. PMID: 39476533 Free PMC article.
References
-
- Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397:2212–2224. - PubMed
-
- Gluckman PD, Hanson MA, Spencer HG. Predictive adaptive responses and human evolution. Trends Ecol Evol. 2005;20:527–533. - PubMed
-
- Dale KS, Mann JI, McAuley KA, Williams SM, Farmer VL. Sustainability of lifestyle changes following an intensive lifestyle intervention in insulin resistant adults: Follow-up at 2-years. Asia Pac J Clin Nutr. 2009;18:114–120. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous